GREY:ATBPF - Post by User
Comment by
RjM2018on Apr 04, 2021 10:37pm
198 Views
Post# 32935835
RE:RE:RE:Hoping for a rise
RE:RE:RE:Hoping for a riseI've been holding since before phase 1 and have added significantly over the years.
I'm curious about what you mean by pharm deal? Does this mean deals for Otena in: Latin America, Europe, & or USA?
If we strike a pharma deal for Otena in LATM, Eur, and USA, without any advancement of our other products I will likely sell 65-75% of my stock. Rationale: big pharma won't likely buyout the company for the H2S platform without evidence that other molecules show promise in humans.
For me, it depends on how quickly we can accelerate human trials for ATB-352/340. If we can get one of these molecule into phase 1, that changes the game completely. We're now looking at sell-ing off a platform vs a single molecule.
We are often citing Dr. Haut's AskBio $4Billion deal to Bayer as a reference. This was an AAV gene therapy company (aka a platform) with 3 molecules in early stage clinical trials (currently they have 3 phase1/2 trials in humans).
I beleive fully this compacy is worth several billions of dollars as it solves a longstanding problem with existing NSAIDS. It all depends on whether management can play their cards correctly to maximize market capitilzation and buyout.
Again, I've been here, and will continue to be here until a buyout, just my 2 cents...
Good luck to longs,
RjM